Vitamins C and K3 Sensitize Human Urothelial Tumors to Gemcitabine

« Previous Next »The Journal of Urology
Volume 176, Issue 4 , Pages 1642-1647, October 2006

Wassim Kassouf
- Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Ralph Highshaw
- Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Gina M. Nelkin
- Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Colin P. Dinney
- Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
- Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
- Financial interest and/or other relationship with AstraZeneca, GlaxoSmithKline, National Cancer Institute, Canji/Schering-Plough and Abbott/Vysis.
Ashish M. Kamat
- Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
- Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
- Financial interest and/or other relationship with Healthgate, Pharmacia and Abbott.
- Correspondence and requests for reprints: Departments of Urology and Cancer Biology, Unit 1373, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030 (telephone: 713-792-3250; FAX: 713-794-4824)